Scientific Sessions 2024  /  Annual Lipid Updates - 2024  /  Lipoprotein(a): Modifiable Risk Factor, Update in Targeted Therapies
Logo

American Heart Association

  2
  0

Final ID:

Lipoprotein(a): Modifiable Risk Factor, Update in Targeted Therapies

  • Yeang, Calvin  ( University of California San Diego , San Diego , California , United States )
  • Bhatia, Harpreet  ( University of California San Diego , San Diego , California , United States )
  • Mehta, Anurag  ( Virginia Commonwealth University , Glen Allen , Virginia , United States )
    • Author Disclosures:
    Calvin Yeang: DO NOT have relevant financial relationships | Harpreet Bhatia: DO have relevant financial relationships ; Consultant:Kaneka:Past (completed) ; Advisor:Arrowhead:Active (exists now) ; Advisor:Abbott:Active (exists now) ; Advisor:Novartis:Active (exists now) ; Consultant:Novartis:Active (exists now) | Anurag Mehta: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Annual Lipid Updates - 2024

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
New Frontiers in Triglyceride Lowering

Tokgozoglu Lale, Remaley Alan T, Cariou Bertrand, Hudgins Lisa

Controversies in Nutrition and Lipids

Anderson Cheryl, Polonsky Tamar

More abstracts from these authors:
Lipoprotein (a), Triglyceride-Glucose Index and Incident Atherosclerotic Cardiovascular Disease (ASCVD): Analysis of the UK Biobank

Kazibwe Richard, Bhatia Harpreet, Michos Erin, Shapiro Michael, Schaich Christopher, Chevli Parag, Kingsley Jeffrey, Rikhi Rishi, Ahmad Muhammad, Mirzai Saeid, Namutebi Juliana, Mehta Anurag

Managing Obesity and MASLD - Whose Job Is It?

Jastreboff Ania, Woodhouse Sheila, Mehta Anurag

You have to be authorized to contact abstract author. Please, Login
Not Available